Medtronic: Cardiovascular Diseases trials

The registry lists 32 Cardiovascular Diseases studies with Medtronic as lead sponsor. 10 are open to participants now and 9 have results posted.

Phase 3 1Phase 4 1No phase 30(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)RecruitingNCT07585968Not applicable
• Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal DenervationRecruitingNCT07174622
• Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled HypertensionRecruitingNCT07115953Not applicable
• Spyral InSight StudyRecruitingNCT07013929Not applicable
• SPYRAL GEMINI Pilot StudyRecruitingNCT06907147Not applicable
• Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)RecruitingNCT06703489Not applicable
• ELEVATE-HFpEF Clinical StudyRecruitingNCT06678841Not applicable
• Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac SurgeryRecruitingNCT04241328
• Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.RecruitingNCT03242642Not applicable
• Product Surveillance RegistryRecruitingNCT01524276
• SPYRAL DYSTAL Renal Denervation Global Clinical StudyCompletedNCT04311086Not applicableResults posted
• Management of Device Detected AT and Impact of Device Treatment Algorithms on Atrial FibrillationTerminatedNCT04172883Not applicableResults posted
• SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation SystemCompletedNCT02439775Not applicableResults posted
• SPYRAL PIVOTAL - SPYRAL HTN-OFF MED StudyCompletedNCT02439749Not applicableResults posted
• RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary ArteriesCompletedNCT01150500Not applicableResults posted
• RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary StentCompletedNCT00927940Not applicableResults posted
• Medtronic Shock-Less Study on Physician Utilization of Shock Reduction ProgrammingCompletedNCT00856349Results posted
• RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient PopulationCompletedNCT00752128Results posted
• PreFER Managed Ventricular Pacing (MVP) For Elective ReplacementCompletedNCT00293241Phase 4Results posted
• SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTNActive, not recruitingNCT05198674Not applicable
• Destination Therapy Post Approval StudyActive, not recruitingNCT03681210
• RESOLUTE ONYX China Single Arm StudyCompletedNCT03471845Not applicable
• RESOLUTE ONYX China RCT StudyCompletedNCT03466151Not applicable
• China Resolute Integrity 34/38 mm StudyCompletedNCT03118531Not applicable
• Profiling Implantable Cardiac Device Diagnostics Trends During Clinical Events .CompletedNCT03091959
• Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)CompletedNCT02452736Phase 3
• Renal Denervation in Patients With Uncontrolled Hypertension - SYMPLICITY HTN-4CompletedNCT01972139Not applicable
• Endurant™ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (ENDURANT France)CompletedNCT01526811
• RESOLUTE China RCTCompletedNCT01334268Not applicable
• RESOLUTE China Registry:CompletedNCT01243749
• RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in AsiaCompletedNCT01132456Not applicable
• DSS: Diabetes Surgery Study - Intensive Medical Management of Type 2 Diabetes, With and Without Gastric Bypass SurgeryCompletedNCT00641251Not applicable